AugMend Health Company Profile

Background

Company Overview

AugMend Health, founded in 2022 and headquartered in Boston, Massachusetts, is a private company operating in the medical specialists industry. The company employs approximately 25 individuals and generates an estimated annual revenue of $2.1 million.

Mission and Vision

AugMend Health is dedicated to addressing the critical shortage of behavioral health professionals by embedding digital behavioral health software into specialty care clinics. Their mission is to integrate technology seamlessly into existing clinical workflows, thereby enhancing patient care and operational efficiency.

Primary Area of Focus

The company focuses on providing self-guided virtual reality (VR) intake services designed to increase the efficiency of mental health clinics. By leveraging AI and VR technologies, AugMend Health aims to improve patient outcomes and streamline clinical processes.

Key Strategic Focus

Core Objectives

Integration of Digital Tools: Embed comprehensive digital behavioral health tools into specialty clinics to meet the growing demand for behavioral health services.

Enhancement of Provider Capacity: Utilize AI and VR to increase provider capacity, standardize care delivery, and collect meaningful data to improve patient outcomes.

Areas of Specialization

Behavioral Health Assessments: Implement conversational behavioral health assessments and evidence-based exercises in VR to support clinical teams in oncology and pain departments.

Psycho-Education: Provide interactive settings for patients to receive education on complex psychological concepts.

Key Technologies Utilized

Artificial Intelligence (AI): Develop AI-driven tools to streamline documentation by converting patient interactions into electronic health record (EHR)-ready clinical notes.

Virtual Reality (VR): Offer adaptive VR exercises to help patients adopt and maintain generalizable skills and behavioral practices.

Primary Markets Targeted

Specialty Care Clinics: Focus on oncology and pain management clinics facing increased behavioral health demands amid limited resources.

Financials and Funding

Funding History

AugMend Health has participated in two accelerator/incubator funding rounds:

1. September 2022: Completed an accelerator/incubator round.

2. September 2023: Completed another accelerator/incubator round.

Notable Investors

Massachusetts Institute of Technology (MIT): Provided backing as a university investor.

Harvard Innovation Launch Lab: Supported as an accelerator/incubator investor.

Utilization of Capital

The capital raised is intended to further develop and integrate AugMend Health's digital behavioral health tools into specialty care clinics, enhancing patient care and operational efficiency.

Pipeline Development

Key Pipeline Candidates

AugMend Health is currently operating in stealth mode, focusing on the development of self-guided virtual reality intake services aimed at increasing the efficiency of mental health clinics.

Stages of Development

Product Development: Ongoing development of AI and VR tools for behavioral health assessments and exercises.

Target Conditions

Behavioral Health Disorders: Addressing comorbid behavioral health disorders in chronic pain and cancer patients.

Anticipated Milestones

Clinical Integration: Pilot programs to integrate the platform into existing clinical workflows.

Regulatory Approvals: Achieve necessary certifications and compliance for widespread adoption.

Technological Platform and Innovation

Proprietary Technologies

AI-Driven Documentation: Technology that converts patient interactions into EHR-ready clinical notes, streamlining documentation processes.

VR Behavioral Exercises: Adaptive VR exercises designed to help patients adopt and maintain generalizable skills and behavioral practices.

Significant Scientific Methods

Conversational Assessments: Utilizing AI to conduct conversational behavioral health assessments, capturing comprehensive bio-psycho-social profiles for each patient.

Psycho-Education Modules: Interactive VR settings that educate patients on complex psychological concepts.

Leadership Team

Key Executive Profiles

Aleksy Dojnow: Co-Founder & Chief Product Officer (CPO). Details about his professional background and contributions to the company are currently limited.

Leadership Changes

As of the latest available information, there have been no significant changes or appointments within AugMend Health's leadership team.

Competitor Profile

Market Insights and Dynamics

The global human augmentation market, encompassing AI-powered solutions like AugMend Health's, is experiencing significant growth. Valued at approximately USD 253.6 billion in 2023, it is projected to reach USD 545.1 billion by 2028, reflecting a compound annual growth rate (CAGR) of 16.5% during the forecast period. This expansion is driven by the increasing adoption of technologies such as virtual reality (VR) and augmented reality (AR) across various industries, including healthcare.

Competitor Analysis

AugMend Health faces competition from various companies in the digital behavioral health and AI-driven healthcare solutions market. Notable competitors include:

Plexaa: A medtech company focused on improving surgical outcomes for breast cancer patients by preventing skin and nipple necrosis following mastectomies.

inContAlert: A MedTech start-up developing a wearable device to measure the filling level of the urinary bladder, utilizing sensor technology and AI algorithms.

Flat Medical: A medtech company dedicated to developing innovative safety solutions for epidural and central line placements, providing advanced tools to ensure successful and secure procedures.

Strategic Collaborations and Partnerships

AugMend Health has established affiliations with prominent institutions to strengthen its market position and innovation capacity:

Massachusetts Institute of Technology (MIT): Provided backing as a university investor.

Harvard Innovation Launch Lab: Supported as an accelerator/incubator investor.

Operational Insights

Strategic Considerations

Market Position: AugMend Health aims to position itself as a leader in integrating AI and VR technologies into behavioral health services within specialty care clinics.

Competitive Advantages: The company's focus on seamless integration into existing clinical workflows and the use of immersive technologies to enhance patient care differentiates it from competitors.

Strategic Opportunities and Future Directions

Strategic Roadmap

Product Development: Continue refining AI and VR tools to meet the evolving needs of specialty care clinics.

Market Expansion: Explore opportunities to expand services beyond oncology and pain management into other specialty areas.

Opportunities for Expansion

Partnerships: Forge additional collaborations with healthcare institutions to broaden the adoption of AugMend Health's platform.

Technology Enhancement: Invest in research and development to enhance the capabilities of AI and VR applications in behavioral health.

Positioning for Future Objectives

By leveraging its current strengths in AI and VR integration, AugMend Health is well-positioned to address the growing demand for behavioral health services and to achieve its future objectives in enhancing patient care and operational efficiency.